Biotechnology
Swiss companies operating in the same biotechnology industry
The table below has Swiss companies that operate under the same industry, biotechnology. This list helps you analyze each company’s performance, income statements, and stock activity — all in one place. Sort by key metrics to find the most expensive stocks like LONZA GROUP AG, or spot the most traded options, such as KUROS N. Ideal for investors and traders looking to build or refine a strategy within this growing tech segment.
Symbol | Market cap | Price | Change % | Volume | Rel Volume | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst Rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 AMGAMGEN INC | 131.41 B CHF | 246.142 CHF | +4.38% | 1 | 0.22 | 25.38 | 9.70 CHF | +53.72% | 3.02% | Health technology | Buy |
 CSJCSL LTD | 68.13 B CHF | 137.062 CHF | +5.04% | 10 | 0.06 | 28.48 | 4.81 CHF | +6.92% | 1.58% | Health technology | Strong buy |
 LO3LONZA GROUP AG | 38.74 B CHF | 567.095 CHF | +0.55% | 46 | 0.47 | 55.53 | 10.21 CHF | +25.53% | 0.71% | Health technology | Strong buy |
| LONNLONZA N | 38.74 B CHF | 567.0 CHF | +0.11% | 105.03 K | 0.87 | 55.52 | 10.21 CHF | +25.53% | 0.71% | Health technology | Strong buy |
 QTSIQVIA HOLDINGS INC | 26.99 B CHF | 128.182 CHF | −33.18% | 60 | — | 23.40 | 5.48 CHF | −20.98% | 0.00% | Health technology | Buy |
 22UABIONTECH SEDR | 22.1 B CHF | 91.392 CHF | +0.78% | 23 | 0.28 | — | −3.04 CHF | −804.25% | 0.00% | Health technology | Buy |
 0QFMODERNA INC | 10.53 B CHF | 27.463 CHF | −2.56% | 16 | 0.06 | — | −7.72 CHF | +45.40% | 0.00% | Health technology | Neutral |
 BM8BIOMARIN PHARMA | 9.02 B CHF | 47.688 CHF | +2.40% | 100 | 0.35 | 19.99 | 2.39 CHF | +147.50% | 0.00% | Health technology | Buy |
 1CGCRISPR THERAPEUTIC | 4.46 B CHF | 52.990 CHF | −3.30% | 750 | 4.72 | — | −4.00 CHF | −62.81% | 0.00% | Health technology | Buy |
 38IINTELLIA THERAPEUT | 1.12 B CHF | 9.658 CHF | +18.60% | 300 | 1.64 | — | −4.63 CHF | +4.39% | 0.00% | Health technology | Buy |
 YTSNKUROS BIOSCIENCES | 1.06 B CHF | 27.540 CHF | +2.84% | 250 | 0.73 | — | −0.12 CHF | +69.27% | 0.00% | Health technology | Strong buy |
| KURNKUROS N | 1.06 B CHF | 29.00 CHF | +4.09% | 209.2 K | 0.78 | — | −0.12 CHF | +69.27% | 0.00% | Health technology | Strong buy |
 5CVCUREVAC NV | 980.03 M CHF | 4.281 CHF | −1.34% | 30 | 0.53 | 5.36 | 0.80 CHF | — | 0.00% | Health technology | Neutral |
 PPGNPOLYPEPTIDE N | 817.52 M CHF | 24.75 CHF | −3.70% | 39.84 K | 1.32 | — | −0.57 CHF | +62.88% | 0.00% | Health technology | Neutral |
| 8H0POLYPEPTIDE GROUP | 817.52 M CHF | 24.743 CHF | +20.95% | 100 | 0.25 | — | −0.57 CHF | +62.88% | 0.00% | Health technology | Neutral |
 VLAVALNEVA SE | 515.63 M CHF | 3.071 CHF | −3.15% | 170 | 0.13 | — | −0.50 CHF | −191.70% | 0.00% | Health technology | Strong buy |
 MOLNMOLECULAR PARTNERS N | 131.22 M CHF | 3.250 CHF | +1.09% | 13.32 K | 0.68 | — | −1.71 CHF | +4.14% | 0.00% | Health technology | Strong buy |
 BIOVBIOVERSYS N | — | 34.0 CHF | +0.59% | 746 | 0.32 | — | — | — | — | Health technology | Strong buy |